You signed in with another tab or window. Reload to refresh your session.You signed out in another tab or window. Reload to refresh your session.You switched accounts on another tab or window. Reload to refresh your session.Dismiss alert
Hedge3 is a non-custodial, and decentralised DeFi aggregating platform. Designed for investors Hedge3 strives to provide the best investment opportunities for its users, thus our goal is to find and integrate trusted and unique in aggregation market investment mechanisms like Enzyme’s public vaults.
Simplified, Hedge3 is a new and common front-end for several different investment protocols like Yield Farmings, Landings, Asset Management Funds, Indices, and more.
Hedge3 users explore investment opportunities and deposit into contracts using Hedge3 UI, while our intermediary contracts place the user's assets on the appropriate provider’s contracts.
Synergies/benefits to the Enzyme ecosystem
Hedge3 benefit: By listing Enzyme’s publicly traded vaults Hedge3 makes its product more interesting for investors.
Enzyme benefit: Enzyme finance and its publicly traded vaults are getting liquidity from Hedge3 users, Hedge3 directly impacts on AUM growth of Enzyme’s vaults!
We believe Hedge3 and Enzyme have many common interests and looking forward to a long-term partnership.
Needs
Hedge3 is a non-custodial platform that sends all users' deposits directly to its partners. Because of this, Hedge3 makes money through referral fees from the providers.
Hedge3 wants to work with Enzyme and is asking them for a collaboration plan. In this partnership, Enzyme would share a part of the money they make from Hedge3's intermediary contract back with Hedge3.
Meantime Hedge3 asks Enzyme council to approve the Hedge3 intermediary contract to interact with Enzyme’s contracts in order to deposit and withdraw on behalf of Hedge3 users.
It is worth also mentioning that if Enzyme would create an automated referral system and announce it to the market, more aggregators would be interested in integrating with Enzyme public vaults providing additional AUM to them.
Once the Enzyme Council approves the contract, the Hedge3 MVP can be regarded as complete and ready.
Another month can be spent on platform upgrades, contract audits, and go-to-market preparations.
Team presentation
CEO and one of the co-founders of the project is Jacob Grigoryan, he has 10 years of experience as a web entrepreneur of which 5 years as a co-founder and COO of the web3 software development company Exio Tech.
The CTO and co-founder of Hedge3 is Tatevik Baghdasaryan, she is a PhD in Computer Science specializing in Information Security, she started her career as a network security administrator, then switched to software development where she reached the position of Lead Engineer at Siemens EDA, last couple of years she got inspired by blockchain technologies and wishes to switch to solidity development permanently.
Description of the project
Hedge3 is a non-custodial, and decentralised DeFi aggregating platform. Designed for investors Hedge3 strives to provide the best investment opportunities for its users, thus our goal is to find and integrate trusted and unique in aggregation market investment mechanisms like Enzyme’s public vaults.
Simplified, Hedge3 is a new and common front-end for several different investment protocols like Yield Farmings, Landings, Asset Management Funds, Indices, and more.
Hedge3 users explore investment opportunities and deposit into contracts using Hedge3 UI, while our intermediary contracts place the user's assets on the appropriate provider’s contracts.
Synergies/benefits to the Enzyme ecosystem
Hedge3 benefit: By listing Enzyme’s publicly traded vaults Hedge3 makes its product more interesting for investors.
Enzyme benefit: Enzyme finance and its publicly traded vaults are getting liquidity from Hedge3 users, Hedge3 directly impacts on AUM growth of Enzyme’s vaults!
We believe Hedge3 and Enzyme have many common interests and looking forward to a long-term partnership.
Needs
Hedge3 is a non-custodial platform that sends all users' deposits directly to its partners. Because of this, Hedge3 makes money through referral fees from the providers.
Hedge3 wants to work with Enzyme and is asking them for a collaboration plan. In this partnership, Enzyme would share a part of the money they make from Hedge3's intermediary contract back with Hedge3.
Meantime Hedge3 asks Enzyme council to approve the Hedge3 intermediary contract to interact with Enzyme’s contracts in order to deposit and withdraw on behalf of Hedge3 users.
It is worth also mentioning that if Enzyme would create an automated referral system and announce it to the market, more aggregators would be interested in integrating with Enzyme public vaults providing additional AUM to them.
The Contract
Github:
https://github.com/hapo92/hedge3-contracts/blob/main/integrations/enzyme/hedge3-enzyme.sol
PolygonScan:
https://polygonscan.com/address/0x94941135333186b91bbAE2353724B3de2811C1A3
Clear timeline
Once the Enzyme Council approves the contract, the Hedge3 MVP can be regarded as complete and ready.
Another month can be spent on platform upgrades, contract audits, and go-to-market preparations.
Team presentation
CEO and one of the co-founders of the project is Jacob Grigoryan, he has 10 years of experience as a web entrepreneur of which 5 years as a co-founder and COO of the web3 software development company Exio Tech.
The CTO and co-founder of Hedge3 is Tatevik Baghdasaryan, she is a PhD in Computer Science specializing in Information Security, she started her career as a network security administrator, then switched to software development where she reached the position of Lead Engineer at Siemens EDA, last couple of years she got inspired by blockchain technologies and wishes to switch to solidity development permanently.
Contact information
GM: grigoryanjacob[@]gmail.com
TG: https://t.me/jacobgrigoryan
The text was updated successfully, but these errors were encountered: